project id: TCGA-LUSC; case submitter id: TCGA-85-A5B5; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 7.3; age at index: 58; days to birth: -21450; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 21450; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 111.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; years smoked: 29.0; is ffpe: false; composition: Not Reported; days to collection: 190; days to sample procurement: 0; initial weight: 115.0; portion submitter id: TCGA-85-A5B5-01A-21; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 2.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 55.0; percent tumor cells: 35.0; percent tumor nuclei: 65.0;